SCHEMBL22309346

SCHEMBL22309346

CC1(C)c2ccccc2-c2cc(-c3cc(-c4cccc(-c5cccc(-c6nc(-c7ccccc7)nc(-c7cccc8c7oc7c(-c9ccccc9)cccc78)n6)c5)c4)nc(-c4ccccc4)n3)ccc21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.39
KMT2A Q03164 6/20 0.39
ALDH1A1 P00352 6/20 0.39
MAPT P10636 6/20 0.39
HPGD P15428 6/20 0.39
KDM4E B2RXH2 4/20 0.39
LMNA P02545 2/20 0.39
GLA P06280 1/20 0.39
ACACA Q13085 2/20 0.34
NTSR1 P30989 1/20 0.33
PDK2 Q15119 4/20 0.32
PRKDC P78527 4/20 0.31
PIK3CD O00329 1/20 0.31
PIK3CA P42336 1/20 0.31
PIK3CB P42338 1/20 0.31
PIK3CG P48736 1/20 0.31
MTOR P42345 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
RXFP1 Q9HBX9 1/20 0.31
CYP2C19 P33261 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17425599 0.96 PRKDC (0.33) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL22308664 0.95 MEN1 (0.38) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL22309553 0.94 MEN1 (0.39) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL17425590 0.94 ALDH1A1 (0.34) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL22309447 0.93 ALOX5 (0.38) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL17425725 0.93 ALDH1A1 (0.33) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL22308640 0.92 ALOX5 (0.39) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL22309978 0.92 MEN1 (0.37) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL17425594 0.92 PDK2 (0.34) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL17425726 0.92 ALOX5 (0.35) MEN1KMT2AALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11917910-B2 Organic compound and organic electroluminescent device using the same SOLUS ADVANCED MATERIALS CO., LTD. (KR) 2024-02-27 US disclosed
US-11917910-B2 Organic compound and organic electroluminescent device using the same SOLUS ADVANCED MATERIALS CO., LTD. (KR) 2024-02-27 US disclosed
US-20200251659-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME DOOSAN CORPORATION (KR) 2020-08-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200251659-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME VDAC1, OR10J3, PIEZO1 MEN1 2484/4885KMT2A 2549/4885ALDH1A1 644/4885
US-11917910-B2 Organic compound and organic electroluminescent device using the same VDAC1, OR10J3, PIEZO1 MEN1 2484/4885KMT2A 2549/4885ALDH1A1 644/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.